4/A//SEC Filing
Alam Kamran 4/A
Accession 0001415889-25-010539
CIK 0001806310other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:15 PM ET
Size
5.8 KB
Accession
0001415889-25-010539
Insider Transaction Report
Form 4/AAmended
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2023-05-31+12,462→ 12,462 totalExercise: $1.18Exp: 2033-02-02→ Common Stock (12,462 underlying)
Footnotes (1)
- [F1]The option was awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The shares underlying the option covered by this report vested upon certification. This option was inadvertently omitted for the original Form 4.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001793412
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:15 PM ET
- Size
- 5.8 KB